Galmed Pharmaceuticals Ltd. ( GLMD) - Key Metrics
Stock symbol GLMD is outdated, potentially delisted? Maybe it is available on other exchange?
Ticker GLMD was renamed to
EOCN
effective 2026-09-10.
GLMD Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$2.86 | -$2.23 | -$2.23 |
| 2026Q1 | $0 | -$2.32 | -$3.08 | -$3.08 |
| 2025Q4 | $0 | -$5.86 | -$2.36 | -$2.36 |
| 2025Q3 | $0 | -$2.77 | -$2.83 | -$2.83 |
| 2025Q2 | $0 | -$5.06 | -$2.57 | -$2.57 |
GLMD Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.39 |
| 2026Q1 | 0% | -0.42 |
| 2025Q4 | 0% | -0.26 |
| 2025Q3 | 0% | -0.99 |
| 2025Q2 | 0% | -0.73 |
GLMD
Price: $4.63
52 week price:
Earnings Per Share: -14.29 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Israel
Volume: 176487
Ebitda: -2.7 millionMarket Capitalization: 4.1 million